With rates and deaths associated with Clostridium difficile (C. difficile), a pathogen that can cause diarrhea, at a historically high level, the Society for Healthcare Epidemiology of America (SHEA) recommends increasing prevention efforts aimed at controlling the spread of C. difficileincluding good hand hygiene and antimicrobial stewardship. Unnecessary antibiotic use can create an environment for C. difficile to grow and create serious health issues. To help eliminate inappropriate use of these drugs, antimicrobial stewardship programs and interventions help guide prescribers understanding of when antibiotics are needed and what the best treatment choices are for a particular patient.
Nearly 50 percent of antibiotics are inappropriately prescribed, killing off the natural protective bacteria in our gut, says Jan E. Patterson, MD, MS, president of SHEA. The increased prevalence in C. difficile demonstrates the need for better control and use of antibiotics, not only to preserve the efficacy of these life saving drugs, but to prevent adverse events like C. difficile infection.
C. difficile can spread from person-to-person on contaminated equipment and on the hands of healthcare professionals and visitors. But C. difficile infections can be prevented. In the Compendium of Strategies to Prevent Healthcare-Associated Infections, SHEA recommends that health professionals clean hands with soap and water during outbreaks to prevent transmission of C. difficile infections. Evidence shows that soap and water is superior to alcohol-based sanitizers for removing C. difficile spores. Healthcare professionals should also follow contact precautions and wear gloves when entering the room of a patient with C. difficile.Â
CDCs Vital Signs report found 337,000 cases of C. difficile occur annually in the U.S. and are linked with about 14,000 deaths, adding at least $1 billion in healthcare costs. In its report, CDC used data collected from the National Healthcare Safety Network (NHSN), a surveillance system that helps monitor healthcare associated infections (HAIs) and adverse events in health settings throughout the U.S. In recent years CDCs budget for NHSN has flat lined and faces severe cuts and greater demands for increased surveillance, often times written into state legislation on infection prevention.
With an increasing need to monitor existing and emerging biological threats, the need for CDC to collect and analyze HAI data is necessary not only for public health, but national security, says Patterson. With these cuts, the nations ability to identify and track infections is severely challenged.Â
CDCs Vital Signs report also found early prevention projects in Illinois, Massachusetts and New York have been showing declines in hospital C. difficile rates. Key factors in these success stories have included a multi-disciplinary team approach, support from hospital administration and a focus on strict adherence to infection control.
Patterson notes, it is important to create a public dialogue about infections such as C. difficile what they are, where they are most likely to occur and how they spread. This is a critical component of increasing our understanding of these infections and ultimately reducing rates of them.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.
The Neglected Tropical Diseases You’ve Never Heard Of
February 27th 2024The 20 conditions, known as neglected tropical diseases (NTDs), are estimated to affect more than 1 billion people, yet many individuals have never heard of them. Heather Saunders, MPH, RN, CIC, discusses 5 of them and what is being done to prevent their spread.